Exploiting the DNA-damage repair defect of BRCA1-deficient pancreatic cancer cells in drug therapy

Hirsch, Georg Steffen

In this study we show that BRCA1-deficient murine pancreatic carcinoma cells are sensitive to DNA damaging drugs like Mitomycin C and Cisplatin.

Preview

Quote

Citation style:

Hirsch, Georg Steffen: Exploiting the DNA-damage repair defect of BRCA1-deficient pancreatic cancer cells in drug therapy.

Rights

Use and reproduction:
No CC License (german copyright law applies)

Export